Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics

Details for Australian Patent Application No. 2006287175 (hide)

Owner Precision Therapeutics, Inc.

Inventors Gabrin, Michael; Nanavati, Payal; Rice, Shara Dawn; Chattopadhyay, Anuja; McDonald, Sean; Gallion, Holly; Brower, Stacey

Agent Allens Arthur Robinson

Pub. Number AU-A-2006287175

PCT Pub. Number WO2007/028146

Priority 60/712,815 01.09.05 US; 60/712,814 01.09.05 US; 60/735,813 14.11.05 US

Filing date 1 September 2006

Wipo publication date 8 March 2007

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/028146 Priority application(s): WO2007/028146

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006287177-Suture-based systems and methods for treating septal defects

2006287173-Immunoglobulins comprising predominantly a GICNAcMan3GIcNAc2 glycoform